Yttrium Microspheres With Cetuximab Plus Irinotecan for Patients With Advanced Colorectal Cancer Mets to Liver

Summary

The goal of this clinical research study is to find out what effects radioactive particles, SIR-spheres, have when injected into the liver, followed by systemic chemotherapy with a combination of cetuximab and irinotecan compared to those who have systemic therapy alone, in patients with colon cancer that has metastasized to the liver. The safety of this treatment and how well it controls the disease will also be studied.

Timeline

Start

2009-10

Primary completion

2012-01

Completion

2012-01

Outcome

Outcome not reported

Stopped (Enrollment): “Slow Accrual and withdrawn/exclusion of 2 participants.”

Drugs

Indications